Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024

SELL
$197.69 - $227.29 $81,843 - $94,098
-414 Reduced 84.66%
75 $17,000
Q3 2023

Nov 09, 2023

BUY
$201.05 - $221.7 $98,313 - $108,411
489 New
489 $98,000
Q3 2022

Nov 09, 2022

BUY
$204.81 - $262.19 $204,810 - $262,190
1,000 New
1,000 $205,000
Q3 2021

Nov 12, 2021

SELL
$274.82 - $308.34 $7.57 Million - $8.5 Million
-27,552 Closed
0 $0
Q2 2021

Aug 10, 2021

BUY
$251.87 - $278.14 $6.94 Million - $7.66 Million
27,552 New
27,552 $7.6 Million
Q1 2021

May 12, 2021

SELL
$204.88 - $255.03 $169,230 - $210,654
-826 Closed
0 $0
Q4 2020

Feb 10, 2021

BUY
$186.91 - $214.42 $154,387 - $177,110
826 New
826 $168,000

Others Institutions Holding LH

About LABORATORY CORP OF AMERICA HOLDINGS


  • Ticker LH
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 89,600,000
  • Market Cap $20.7B
  • Description
  • Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests,...
More about LH
Track This Portfolio

Track Group One Trading, L.P. Portfolio

Follow Group One Trading, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Group One Trading, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Group One Trading, L.P. with notifications on news.